Long-Term Cardiometabolic Outcomes in Children With Metabolically Healthy and Unhealthy Obesity - Report - MDSpire

Long-Term Cardiometabolic Outcomes in Children With Metabolically Healthy and Unhealthy Obesity

  • By

  • Resthie R. Putri

  • Pernilla Danielsson

  • Emilia Hagman

  • Claude Marcus

  • July 1, 2026

  • 0 min

Share

Sustained Cardiometabolic Effects in Pediatric Populations with Healthy versus Unhealthy Obesity

Overview

This study investigates the long-term cardiometabolic risks associated with metabolically healthy obesity (MHO) and metabolically unhealthy obesity (MUO) in children, comparing these groups to their peers from the general population.

Background

Obesity in pediatric populations is a complex condition that can lead to various health complications, including cardiometabolic diseases. This study aims to clarify the differences between MHO and MUO.

Data Highlights

No numerical data was provided in the source material.

Key Findings

  • Children with MHO may not exhibit increased risks of cardiometabolic diseases compared to their peers.
  • Children with MUO show a higher incidence of type 2 diabetes, hypertension, and dyslipidemia.
  • Long-term outcomes for children with MHO remain unclear, necessitating further research.

Clinical Implications

Clinicians should consider the metabolic status of children with obesity when determining treatment approaches. The findings suggest that not all children with obesity require aggressive weight loss interventions, particularly those classified as MHO.

Conclusion

Further research is needed to establish the long-term benefits of treatment in children with MHO.

Related Resources & Content

  1. Pediatric Cardiology, Springer, 2026 -- Associations of Overweight and Obesity Indicators with Cardiometabolic Risk Profile in Children and Adolescents with Congenital Heart Disease
  2. The Journal of Clinical Endocrinology & Metabolism, Oxford Academic, 2026 -- Cross-Site Evaluation of Cardiometabolic Diagnoses in Young Individuals with Congenital Adrenal Hyperplasia: Insights from a PEDSnet Study
  3. BMJ Paediatrics Open, BMJ, 2026 -- Metabolically obese normal weight phenotype in children and adolescents aged 3 to 18 years: a systematic review
  4. The Journal of Clinical Endocrinology & Metabolism, Oxford Academic, 2026 -- Metabolomics: An Emerging Approach for Addressing Prevention, Diagnosis, and Management of Obesity
  5. American Heart Association, 2026 -- New guideline reframes weight as health risk tied to diabetes, kidney and heart conditions
  6. Long-Term Cardiometabolic Outcomes in Children With Obesity, JAMA Pediatrics, 2026
  7. Effect of Semaglutide on Insulin Sensitivity and Cardiometabolic Risk Factors in Adolescents With Obesity: The STEP TEENS Study, PubMed, 2026
  8. New guideline reframes weight as health risk tied to diabetes, kidney and heart conditions | American Heart Association
  9. Long-Term Cardiometabolic Outcomes in Children With Obesity
  10. Effect of Semaglutide on Insulin Sensitivity and Cardiometabolic Risk Factors in Adolescents With Obesity: The STEP TEENS Study - PubMed

Original Source(s)

Related Content